
At Artivion, we partner with vascular surgeons to develop cutting-edge technologies to treat patients with TAAA. We are committed to collecting and sharing clinical data related to our aortic-centered technologies to further the science of aortic disease treatment.
Check out some of our most recent clinical data releases.
CONNECT Study
Objectives
Evaluate clinical and technical success as well as safety and feasibility of the E-xtra Design MultiBranch Stent Graft System, when used for the treatment of TAAA.
General Study Information
- Observational, prospective, multicenter study
- PCI: Prof. Schelzig, Düsseldorf, Germany
- 44 patients with thoracoabdominal aneurysm were treated
- 8 centers (7 DE, 1 ES)
- 3 years Follow-Up planned
- CoreLab: Dr. Kerezsy, Passau, Germany

* Intent-To-Treat (ITT): defined as all subjects enrolled in the study who attended the procedure
** 2 Patent treated branch vessels 24h after the index procedure
First Interim Results (4-6 weeks Follow-Up)

1. Fernandez, C. C. et al. Standard off-the-shelf versus custom-made multibranched thoracoabdominal aortic stent grafts.
J Vasc Surg 63, 1208-1215, doi:10.1016/j.jvs.2015.11.035 (2016).
2. Hu, Z. et al. Multibranched Stent-Grafts for the Treatment of Thoracoabdominal Aortic Aneurysms: A Systematic Review and Meta-analysis.
J Endovasc Ther 23, 626-633, doi:10.1177/1526602816647723 (2016).
3. Data on file at JOTEC GmbH
Additional Studies
CELER Registry
Inner branched complex aortic repair outcomes from a national multicenter registry using the
E-xtra design platform
INBREED Registry
Early Outcomes of a Novel Off the Shelf Preloaded Inner Branch Endograft for the Treatment of Complex Aortic Pathologies in the ItaliaN Branched Registry of E-nside EnDograft (INBREED)
EXTENT Study
Medium-term Outcomes of
E-xtra Design Engineering inner branch Endografts for the Treatment of Complex Aortic Aneurysms from a Multicentre Collaboration.
Caution: All products and indications are not available/approved in all markets. The availability of custom-made devices is subject to local regulatory guidelines. E-xtra Design MultiBranch Stent Graft System is a custom-made device for a particularly identified patient manufactured by JOTEC GmbH. All trademarks are owned by Artivion, Inc, or its subsidiaries. JOTEC GmbH is a wholly owned subsidiary of Artivion, Inc. MWENG0024.003 (2024-12)
JOTEC GmbH, Lotzenäcker 23, 72379 Hechingen, Germany
Advancing Aortic Technologies with Purpose™
©2024 Artivion, Inc. | Privacy Policy | Terms of Use